Page last updated: 2024-09-04

jtt 501 and isoxazoles

jtt 501 has been researched along with isoxazoles in 17 studies

Compound Research Comparison

Studies
(jtt 501)
Trials
(jtt 501)
Recent Studies (post-2010)
(jtt 501)
Studies
(isoxazoles)
Trials
(isoxazoles)
Recent Studies (post-2010) (isoxazoles)
21018,6339003,337

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (41.18)18.2507
2000's10 (58.82)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anai, M; Asano, T; Fukushima, Y; Funaki, M; Inukai, K; Ishihara, H; Katagiri, H; Kikuchi, M; Ogihara, T; Oka, Y; Onishi, Y; Sakoda, H; Shibata, T; Terasaki, J; Yazaki, Y1
Iwao, M; Onogi, S; Shibata, T; Shinkai, H; Tanaka, M; Uchida, I; Wakitani, K1
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F2
Matsui, K; Nagao, K; Shibata, T; Shinkai, H; Wakitani, K; Yonemori, F1
Fujita, T; Haneda, M; Hidaka, H; Kashiwagi, A; Kikkawa, R; Kojima, H; Maegawa, H; Morino, K; Nishio, Y; Obata, T; Shibata, T; Ugi, S; Yasuda, H1
Kadowaki, T1
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F1
Inoue, S; Murakami, T; Osaka, T; Yamazaki, Y1
Chan, O; Giacca, A; Kawamori, R; Mathoo, JM; Niwa, M; Rashid, S; Shum, K; Tchipashvili, V; Vranic, M1
Hisatome, I; Ogino, K; Shigemasa, C; Shimoyama, M; Uchida, K1
Hasegawa, M; Makino, H; Nishimiya, T; Ochi, M; Onuma, H; Osawa, H; Tang, Y1
Abe, I; Eto, K; Fujishima, M; Nakamura, Y; Ohya, Y1
Shinkai, H1
Yamanouchi, T1
Basileo, G; Breda, M; James, CA1
Gao, XP; Liu, ZR; Wang, XC; Zhong, CB; Zhu, XJ1

Reviews

3 review(s) available for jtt 501 and isoxazoles

ArticleYear
[Insulin-sensitizing agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:3

    Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Isoxazoles; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones

1999
[The chemical structure and pharmacological properties of a novel isoxazolidinedione insulin sensitizer, JTT-501].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:11

    Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Isoxazoles; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Transcription Factors

2001
[Chemical structures and pharmacological characteristics of novel non-thiazolidinedione insulin sensitizer (JTT-501, FK614)].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Animals; Blood Glucose; Drug Design; Humans; Hypoglycemic Agents; Insulin Resistance; Isoxazoles; Lipid Metabolism; Oxadiazoles; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors

2002

Other Studies

14 other study(ies) available for jtt 501 and isoxazoles

ArticleYear
Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet.
    Diabetologia, 1998, Volume: 41, Issue:4

    Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Cell Membrane; Cells, Cultured; Dietary Fats; Glucose Clamp Technique; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Isoxazoles; Kinetics; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins

1998
Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents.
    Journal of medicinal chemistry, 1998, May-21, Volume: 41, Issue:11

    Topics: 3T3 Cells; Animals; Blood Glucose; Cell Differentiation; Drug Evaluation, Preclinical; Hypoglycemic Agents; Insulin; Isoxazoles; L Cells; Male; Malonates; Mice; Oxazoles; Triglycerides

1998
JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
    British journal of pharmacology, 1998, Volume: 125, Issue:8

    Topics: Animals; Blood Glucose; Disease Models, Animal; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Isoxazoles; Leptin; Lipids; Male; Obesity; Oxidation-Reduction; Phosphorylation; Proteins; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Triglycerides

1998
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    European journal of pharmacology, 1999, Jan-08, Volume: 364, Issue:2-3

    Topics: 3T3 Cells; Administration, Oral; Animals; Blood Glucose; Cell Differentiation; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Isoxazoles; Male; Mice; Mice, Inbred Strains; Oxidation-Reduction; Pioglitazone; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone

1999
A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.
    Diabetologia, 1999, Volume: 42, Issue:2

    Topics: Animals; Blood Glucose; Drug Synergism; Glucose; Glucose Clamp Technique; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Immunosorbent Techniques; Insulin; Isoxazoles; Male; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Signal Transduction

1999
Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
    European journal of pharmacology, 1999, May-28, Volume: 373, Issue:1

    Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Isoxazoles; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides

1999
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone

2000
JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:5

    Topics: Animals; Blood Glucose; Female; Hypertriglyceridemia; Hypoglycemic Agents; Hypothalamus, Middle; Insulin; Isoxazoles; Lipoprotein Lipase; Obesity; Rats; Rats, Wistar; Triglycerides

2000
Effect of JTT-501 on net hepatic glucose balance and peripheral glucose uptake in alloxan-induced diabetic dogs.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:7

    Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Glucagon; Glucose; Hypoglycemic Agents; Insulin; Isoxazoles; Liver; Male

2000
Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts.
    European journal of pharmacology, 2000, Jul-14, Volume: 400, Issue:1

    Topics: Animals; Chromans; Dose-Response Relationship, Drug; Hemodynamics; Hypoglycemic Agents; Indomethacin; Isoxazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Pioglitazone; Prostaglandins; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; Vitamin E

2000
Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse.
    European journal of endocrinology, 2001, Volume: 145, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Adipose Tissue; Animals; Blood Glucose; Blotting, Western; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus; Diabetes Mellitus, Experimental; Epididymis; Fatty Acids; Female; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Insulin; Insulin Resistance; Isoxazoles; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; RNA, Messenger; Triglycerides

2001
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
    European journal of pharmacology, 2001, Jun-29, Volume: 423, Issue:1

    Topics: Analysis of Variance; Animals; Barium; Calcium; Chromans; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Humans; Insulin Resistance; Ion Channels; Isoxazoles; Membrane Potentials; Muscle, Smooth, Vascular; Pioglitazone; Potassium Channels; Prostaglandin D2; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone

2001
Simultaneous determination of JTT-501 and its main metabolite in human plasma by liquid chromatography-ionspray mass spectrometry.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Aug-25, Volume: 794, Issue:1

    Topics: Chromatography, High Pressure Liquid; Humans; Hypoglycemic Agents; Isoxazoles; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization

2003
[Design, synthesis and insulin-sensitizing activity of some peroxisome proliferator-activated gamma agonists].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:2

    Topics: 3T3-L1 Cells; Animals; Glucose; Hypoglycemic Agents; Insulin; Isoxazoles; Mice; PPAR gamma

2005